1
RAPID, HIGH EFFICIENCY PURIFICATION OF MYOFILAMENT PROTEINS USING TOBACCO ETCH VIRUS PROTEASE Mengjie Zhang, Jody L. Martin, Pieter P. De Tombe, Ramzi J. Khairallah Loyola University Chicago, Dept. of Cell and Molecular Physiology, Maywood, IL, USA. Abstract Introduction Results Methods As more and more cardiomyopathy causing mutations are identified, functional studies investigating contractility and myofilament mechanics with mutated proteins become more crucial. Several methods are available, but most rely on exchanging recombinant protein into permeabilized heart cells or myofilament preparation. However, success requires large amounts of highly purified myofilament proteins, a process which is usually different for each individual protein. Here, we describe one single method that can be used for purifying myofilament protein, including troponin T, I and C, as well as myosin light chain 2, which has also been adapted to other recombinant proteins. Previous traditional purification methods TnC: Cellulose DEAE (D52) anion exchange followed by a Phenyl Sepharose hydrophobic interaction TnI: CM Sepharose weak cation followed by a custom TnC capture column TnT: Cellulose DEAE (DEAE FF) anion exchange Disadvantages Time-consuming: 3 days purification + 3 days dialysis Labor intensive: 10 different buffers for the three troponins Low yield: 1-3 mg target protein per liter of bacterial culture. Kobayashi T, Solaro RJ. Increased Ca2+ affinity of cardiac thin filaments reconstituted with cardiomyopathy-related mutant cardiac troponin I. J Biol Chem. 2006 Biesiadecki BJ, Kobayashi T, Walker JS, Solaro RJ, de Tombe PP. The troponin C G159D mutation blunts myofilament desensitization induced by troponin I Ser23/24 phosphorylation. Circ Res. 2007. Tropea JE, Cherry S, Waugh DS. Expression and purification of soluble His 6 -tagged TEV protease. Methods in Mol Biol. 2009. Golovanov AP, Hautbergue GM, Wilson SA, Lian LY. A simple method for improving protein solubility and long-term stability. J Am Chem Soc. 2004. Morjana N, Tal R. Expression and equilibrium denaturation of cardiac troponin I: stabilization of a folding intermediate during denaturation by urea. Biotechnol Appl Biochem. 1998;28:7-17. References & Acknowledgements General workflow for the purification of His-tagged proteins. Schematic of pET 28 vector for expression of target proteins. ÄKTA FPLC Automated Protein Purification System PKA Concentration (μl/ml) 0 1 5 10 50 100 500 1000 0 ATP 5mM ATP Total Protein rPKA fragment Phospho-rTnI rPKA fragment rPKA fragment Total rTnI PKA Concentration (μl/ml) 0 1 5 10 50 100 Recombinant His 6 -PKA Commercial PKA (from bovine heart) Goal: Employ a cleavable tag (His 6 ) to help with the purification without altering the native sequence of the protein Improvements Much more rapid: ~2 days purification Lower labor cost (automated, 4 buffers only) Increased yield: TnC: ~30 mg per liter culture; TnT and TnI: ~15 mg per liter culture. Unified purification procedure 1 st FPLC run His-Tag purification of TnT 2 nd FPLC run Removal of protease 0 20 40 60 0 10 20 0 50 100 150 Absorbance (mAU) Conductivity (mS / cm) Cumulative Volume (ml) 0 20 40 60 80 100 Concentration (%Eluent) Tn Complex TnC TnI Elution with KCl 3 rd FPLC run Complex Purification 75 50 37 25 20 15 10 cTnT-myc cTnI cTnC Troponin complex Eluted Fractions 1 2 3 4 5 6 7 8 9 10 11 12 Troponin C Troponin T Troponin I PKAα MLC2 50 37 25 20 15 10 50 37 25 20 15 10 50 37 25 20 15 10 M 1 2 3 4 M 1 2 3 4 M 1 2 3 4 50 37 25 20 15 10 M 1 2 50 37 25 20 15 10 M 1 2 3 4 Lane 1: Bacterial Lysate Lane 2: After 1 st FPLC run Lane 3: After Protease Digest Lane 4: After 2 nd FPLC run Purification of Myofilament Proteins His-rPKA can phosphorylate TnI TEV Protease Native Cleavage Sequence is ENLYFQ\G Will cleave at EXLYΦQ\φ X is any residue –Φ Large hydrophobic –φ small hydrophobic P1’ specificity of TEV protease Transform and grow bacteria Lysis bacterial pellet 6M Urea Load on HisTrap column and elute His-tagged protein Perform buffer exchange with desalting column Digestion buffer Mix TnT, TnI and TnC in equal amounts Fold proteins into complex by sequential dialysis Relax buffer Digest His-tag with TEV Protease Load on MonoQ column collect peak fractions eluting past 0.4 M KCl Load on HisTrap and collect flowthrough Perform buffer exchange on flowthrough 6M Urea Store proteins in 6M Urea at -80ºC for further use Concentrate using spin column to 2mg/ml 1 st FPLC run 2 nd FPLC run 3 rd FPLC run

BPS Poster 2015 MZ

Embed Size (px)

Citation preview

Page 1: BPS Poster 2015 MZ

RAPID, HIGH EFFICIENCY PURIFICATION OF MYOFILAMENT PROTEINS USING

TOBACCO ETCH VIRUS PROTEASE Mengjie Zhang, Jody L. Martin, Pieter P. De Tombe, Ramzi J. Khairallah

Loyola University Chicago, Dept. of Cell and Molecular Physiology, Maywood, IL, USA.

Abstract

Introduction

Results Methods

As more and more cardiomyopathy causing mutations are

identified, functional studies investigating contractility and

myofilament mechanics with mutated proteins become

more crucial. Several methods are available, but most rely

on exchanging recombinant protein into permeabilized

heart cells or myofilament preparation. However, success

requires large amounts of highly purified myofilament

proteins, a process which is usually different for each

individual protein. Here, we describe one single method

that can be used for purifying myofilament protein,

including troponin T, I and C, as well as myosin light chain

2, which has also been adapted to other recombinant

proteins.

• Previous traditional purification methods

• TnC: Cellulose DEAE (D52) anion exchange followed

by a Phenyl Sepharose hydrophobic interaction

• TnI: CM Sepharose weak cation followed by a custom

TnC capture column

• TnT: Cellulose DEAE (DEAE FF) anion exchange

• Disadvantages

• Time-consuming: 3 days purification + 3 days dialysis

• Labor intensive: 10 different buffers for the three

troponins

• Low yield: 1-3 mg target protein per liter of bacterial

culture.

• Kobayashi T, Solaro RJ. Increased Ca2+ affinity of cardiac thin

filaments reconstituted with cardiomyopathy-related mutant cardiac

troponin I. J Biol Chem. 2006

• Biesiadecki BJ, Kobayashi T, Walker JS, Solaro RJ, de Tombe PP.

The troponin C G159D mutation blunts myofilament desensitization

induced by troponin I Ser23/24 phosphorylation. Circ Res. 2007.

• Tropea JE, Cherry S, Waugh DS. Expression and purification of

soluble His6-tagged TEV protease. Methods in Mol Biol. 2009.

• Golovanov AP, Hautbergue GM, Wilson SA, Lian LY. A simple

method for improving protein solubility and long-term stability. J Am

Chem Soc. 2004.

• Morjana N, Tal R. Expression and equilibrium denaturation of

cardiac troponin I: stabilization of a folding intermediate during

denaturation by urea. Biotechnol Appl Biochem. 1998;28:7-17.

References & Acknowledgements

General workflow for the purification of

His-tagged proteins.

Schematic of pET 28 vector for expression

of target proteins.

ÄKTA FPLC Automated Protein Purification

System

PKA Concentration (µl/ml)

0 1 5 10 50 100 500 1000

0 ATP

5mM ATP

Total Protein

rPKA fragment

Phospho-rTnI

rPKA fragment

rPKA fragment

Total rTnI

PKA Concentration (µl/ml)

0 1 5 10 50 100

Recombinant His6-PKA

Commercial PKA (from bovine heart)

• Goal: Employ a cleavable tag (His6) to help with the

purification without altering the native sequence of the

protein

•Improvements

• Much more rapid: ~2 days purification

•Lower labor cost (automated, 4 buffers only)

• Increased yield: TnC: ~30 mg per liter culture;

TnT and TnI: ~15 mg per liter culture.

Unified purification procedure

1st FPLC run – His-Tag purification of TnT 2nd FPLC run – Removal of protease

0 20 40 60

0

10

20

0

50

100

150

Ab

so

rban

ce

(mA

U)

Co

nd

ucti

vit

y(m

S/ cm

)

Cumulative Volume (ml)

0

20

40

60

80

100

Co

ncen

trati

on

(%E

luent)

Tn Complex

TnCTnI

Elution with KCl

3rd FPLC run – Complex Purification

75

50

37

25

20

15

10

cTnT-myc

cTnI

cTnC

Troponin complex

Eluted Fractions

1 2 3 4 5 6 7 8 9 10 11 12

Troponin C Troponin TTroponin I

PKAαMLC2

50

37

25

20

15

10

50

37

25

20

15

10

50

37

25

20

15

10

M 1 2 3 4 M 1 2 3 4 M 1 2 3 4

50

37

25

20

15

10

M 1 2

50

37

25

20

15

10

M 1 2 3 4

Lane 1: Bacterial Lysate

Lane 2: After 1st FPLC runLane 3: After Protease DigestLane 4: After 2nd FPLC run

Purification of Myofilament Proteins His-rPKA can phosphorylate TnI

TEV Protease • Native Cleavage Sequence is

ENLYFQ\G

• Will cleave at EXLYΦQ\φ

– X is any residue

– Φ Large hydrophobic

– φ small hydrophobic

P1’ specificity of TEV protease

Transform and grow bacteria

Lysis bacterial pellet6M Urea

Load on HisTrapcolumn and elute

His-tagged protein

Perform buffer exchange with

desalting columnDigestion buffer

Mix TnT, TnI and TnC in equal

amounts

Fold proteins into complex by

sequential dialysisRelax buffer

Digest His-tag with TEV Protease

Load on MonoQcolumn collect peak fractions eluting past

0.4 M KCl

Load on HisTrap and collect flowthrough

Perform buffer exchange on f lowthrough

6M Urea

Store proteins in 6M Urea at -80ºC for

further use

Concentrate using spin column to

2mg/ml

1st FPLC run

2nd FPLC run

3rd FPLC run